July 3, 2017
Ex-JPMA Chair Hatsuo Aoki Japan’s pharmaceutical industry needs to regenerate into a sector where even startups can take a leap as long as they roll out unique medicines, while innovation-dearth older companies would fall, a former industry kingpin says. “Metabolism”...read more